Evidence map›Paper›PMID 41079120›Full record

ArticleFrontiers in oncology2025

Development and validation of a multimodal feature fusion-based model for predicting postoperative recurrence-free survival in locally advanced laryngeal squamous cell carcinoma.

Feng Zhao, Xiaoying Huang, Jiangmiao Li, Junkun He, Jiaxin Liu, Guanwei Chen, Zhe Zhang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Feng Zhao *Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiaoying Huang *Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiangmiao LiDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Junkun HeDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiaxin LiuDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Guanwei ChenDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhe ZhangDepartment of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Given the high postoperative recurrence of locally advanced laryngeal squamous cell carcinoma (LSCC) and American Joint Committee on Cancer (AJCC) staging system prediction limitations, this study aims to construct and validate a postoperative recurrence-free survival (RFS) prediction model using multimodal feature fusion and explore data integration strategies to enhance prediction efficacy. Methods: Data from 278 patients diagnosed with locally advanced LSCC between 2013 and 2024 were collected retrospectively. These data were then separated into a training dataset (n = 196) and a validation dataset (n = 82), using a near 7:3 allocation strategy. By integrating clinicopathological features, preoperative blood markers, and enhanced computed tomography imaging data, we constructed clinicopathological (Clinic-score), radiomics (Rad-score), and two fusion models: feature-level (FF-Model) and decision-level (DF-Model). Model performance was evaluated using the concordance index, time-dependent area under the receiver operating characteristic curve, calibration curve, and decision curve analyses. Improvement in model discriminative ability was assessed using continuous net reclassification improvement (cNRI) and integrated discrimination improvement (IDI). Results: At 24.5 months median follow-up, 95 patients (34.2%) experienced recurrence. In the validation set, the DF-Model significantly outperformed the FF-Model, Rad-score and Clinic-score models, and AJCC stages. Additionally, the DF-Model demonstrated superior calibration and clinical utility, better prediction of 1-year, 3-year, and 5-year RFS through cNRI/IDI analysis, and excellent risk stratification across datasets, AJCC stages, and tumor locations. Conclusion: The multimodal prediction DF-Model effectively integrates multi-source heterogeneous information, significantly improving the prediction accuracy of postoperative RFS in locally advanced LSCC, outperforming the FF-Model, single-modal models, and AJCC staging system, and demonstrating its potential clinical translational value.

Indexed as

decision-level fusionlaryngeal squamous cell carcinomalocally advancedmultimodal featuresrecurrence-free survival

Identifiers

PMID41079120
PMCPMC12507578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.